Generic and Personalized RNAi-Based Therapeutics for a Dominant-Negative Epidermal Fragility Disorder

Journal of Investigative Dermatology - United Kingdom
doi 10.1038/jid.2012.28
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

RNAi-based Cancer Therapeutics: Are We There Yet?

Journal of Pharmacovigilance
2014English

Experimental Therapeutics: A Paradigm for Personalized Medicine

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2009English

Mucosal Delivery of RNAi Therapeutics

RNA Interference from Biology to Therapeutics
2012English

Melanoma Prognostics and Personalized Therapeutics at a Crossroad

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2013English

Personalized Medicines: Reforming Diagnostics and Therapeutics

Journal of Basic & Applied Sciences
2015English

Targeting Genetic Alterations in Protein Methyltransferases for Personalized Cancer Therapeutics

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Development of a RNAi-based Release of Insects Carrying a Dominant Lethal (RIDL) System in Drosophila Melanogaster

Science Bulletin
Multidisciplinary
2015English

Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

A Review on Genetic Dominant Disorder-Polydactyly

International Journal of Trend in Scientific Research and Development
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy